Kaili Wang
Impact in
- Pharmaceutical Science top 5%
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
- Finance 10
- Financial Risk and Volatility Modeling 6
- Financial Markets and Investment Strategies 5
- Co-authors
- Chung-Ying YehChwan‐Yang HongYuchen LinChih‐Jung YaoZhexin NiXinying WangXia XuChristopher B. Barrett
- Journals
- European Journal of Pharmacology (2 papers)Frontiers in Nutrition (2 papers)Arabian Journal of Chemistry (2 papers)Review of Quantitative Finance and Accounting (2 papers)Frontiers in Pharmacology (2 papers)
- Partner nations
- ChinaTaiwanUnited States
In The Last Decade
Kaili Wang
82 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 137
- Pharmaceutical Science 73
- Biomaterials 143
- General Economics, Econometrics and Finance 87
- Rehabilitation 67
- Biochemistry 57
Countries citing papers authored by Kaili Wang
This map shows the geographic impact of Kaili Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaili Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaili Wang more than expected).
Fields of papers citing papers by Kaili Wang
This network shows the impact of papers produced by Kaili Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaili Wang. The network helps show where Kaili Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Kaili Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 12 | |
| 4 | 2022 | 11 | |
| 5 | 2022 | 9 | |
| 6 | 2022 | 8 | |
| 7 | 2022 | 22 | |
| 8 | 2021 | 38 | |
| 9 | 2021 | 1 | |
| 10 | 2021 | 4 | |
| 11 | 2020 | 10 | |
| 12 | 2019 | 5 | |
| 13 | 2019 | 54 | |
| 14 | 2019 | 36 | |
| 15 | [HIV incidence and factor related to lost-to-follow-up among men who have sex with men in Harbin, Heilongjiang]. | 2015 | 2 |
| 16 | [Clinical characteristics of adult influenza inpatients in ten provinces in China and analysis of severe risk factors]. | 2015 | 2 |
| 17 | 2012 | 112 | |
| 18 | 2010 | 43 | |
| 19 | The synergistic effect of tetrandrine on fluconazole in the treatment of vulvo- vaginal candidiasis. | 2009 | 2 |
| 20 | In vitro study on tetrandrine as a synergist to fluconazole in murine model of vaginal candidiasis | 2007 | 6 |
About Kaili Wang
Kaili Wang is a scholar working on Finance, Reproductive Medicine, Complementary and alternative medicine, General Economics, Econometrics and Finance and Rheumatology, having authored 83 papers that have together received 1.4k indexed citations. Recurring topics across this work include Market Dynamics and Volatility (7 papers), Financial Risk and Volatility Modeling (6 papers), Monetary Policy and Economic Impact (5 papers), Financial Markets and Investment Strategies (5 papers), Immunotherapy and Immune Responses (5 papers), RNA Interference and Gene Delivery (4 papers), Drug Transport and Resistance Mechanisms (4 papers) and Reproductive System and Pregnancy (4 papers). The work is most often cited by research in Pharmaceutical Science (73 citations), Biomaterials (143 citations), General Economics, Econometrics and Finance (87 citations), Rehabilitation (67 citations) and Biochemistry (57 citations). Kaili Wang has collaborated with scholars based in China, Taiwan and United States. Frequent co-authors include Chung-Ying Yeh, Chwan‐Yang Hong, Yuchen Lin, Chih‐Jung Yao, Zhexin Ni, Xinying Wang, Xia Xu, Christopher B. Barrett, Wei Wang and Wanhui Liu. Their work appears in journals such as European Journal of Pharmacology, Frontiers in Nutrition, Arabian Journal of Chemistry, Review of Quantitative Finance and Accounting and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.